WallStreetZenWallStreetZen

NASDAQ: ATON
Alphaton Capital Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ATON stock forecasts and price targets.

Forecast return on equity

Is ATON forecast to generate an efficient return?

Forecast return on assets

Is ATON forecast to generate an efficient return on assets?

Company
N/A
Industry
48.68%

ATON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATON$5.89N/AN/A
INAB$2.16$180.00+8,233.33%Buy
BOLT$5.15$50.00+870.87%Buy
APM$1.71N/AN/A
ERNA$1.24N/AN/A
View Top Biotech Stocks

Alphaton Capital Stock Forecast FAQ

What is ATON's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ATON) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Alphaton Capital stock.

What is ATON's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ATON) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 48.68%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.